Literature DB >> 12766139

Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis.

Lee Dobson, Christopher D Sheldon, Andrew T Hattersley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12766139     DOI： 10.2337/diacare.26.6.1940-a

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  9 in total

Review 1.  Understanding cystic-fibrosis-related diabetes: best thought of as insulin deficiency?

Authors:  Lee Dobson; Christopher D Sheldon; Andrew T Hattersley
Journal:  J R Soc Med       Date:  2004       Impact factor: 5.344

2.  Harnessing a nanostructured fluorescence energy transfer sensor for quick detection of extremely small amounts of glucose.

Authors:  Jin Zhang; Xianbin Wang; Longyan Chen; Jiaxin Li; Kevin Luzak
Journal:  J Diabetes Sci Technol       Date:  2013-01-01

3.  Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society.

Authors:  Antoinette Moran; Carol Brunzell; Richard C Cohen; Marcia Katz; Bruce C Marshall; Gary Onady; Karen A Robinson; Kathryn A Sabadosa; Arlene Stecenko; Bonnie Slovis
Journal:  Diabetes Care       Date:  2010-12       Impact factor: 19.112

4.  Accuracy of Continuous Glucose Monitoring Measurements in Normo-Glycemic Individuals.

Authors:  Abimbola A Akintola; Raymond Noordam; Steffy W Jansen; Anton J de Craen; Bart E Ballieux; Christa M Cobbaert; Simon P Mooijaart; Hanno Pijl; Rudi G Westendorp; Diana van Heemst
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

5.  Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes.

Authors:  J L Taylor-Cousar; J S Janssen; A Wilson; C G St Clair; K M Pickard; M C Jones; S J Brayshaw; C S Chacon; C M Barboa; M K Sontag; F J Accurso; D P Nichols; M T Saavedra; J A Nick
Journal:  J Diabetes Res       Date:  2016-11-24       Impact factor: 4.011

6.  Can continuous glucose monitoring predict cystic fibrosis-related diabetes and worse clinical outcome?

Authors:  Mariana Zorron; Fernando Augusto Lima Marson; André Moreno Morcillo; Aline Cristina Gonçalves; Mayra de Souza El Beck; José Dirceu Ribeiro; Antonio Fernando Ribeiro
Journal:  J Bras Pneumol       Date:  2022-04-20       Impact factor: 2.800

Review 7.  Comparison of continuous glucose monitoring to reference standard oral glucose tolerance test for the detection of dysglycemia in cystic Fibrosis: A systematic review.

Authors:  Shanal Kumar; Michael Pallin; Georgia Soldatos; Helena Teede
Journal:  J Clin Transl Endocrinol       Date:  2022-09-27

8.  Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study.

Authors:  Stephen M P O'Riordan; Peter Hindmarsh; Nathan R Hill; David R Matthews; Sherly George; Peter Greally; Gerard Canny; Dubhfeasa Slattery; Nuala Murphy; Edna Roche; Colm Costigan; Hilary Hoey
Journal:  Diabetes Care       Date:  2009-03-11       Impact factor: 19.112

9.  Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance.

Authors:  Saba Sheikh; Lalitha Gudipaty; Diva D De Leon; Denis Hadjiliadis; Christina Kubrak; Nora K Rosenfeld; Sarah C Nyirjesy; Amy J Peleckis; Saloni Malik; Darko Stefanovski; Marina Cuchel; Ronald C Rubenstein; Andrea Kelly; Michael R Rickels
Journal:  Diabetes       Date:  2016-08-05       Impact factor: 9.461
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.